Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In AMMO To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in AMMO between August 19, 2020 and September 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi […]
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Xerox To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Xerox between January 25, 2024 and October 28, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Xerox To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Xerox between January 25, 2024 and October 28, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Flux Power To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Flux Power between November 11, 2022 and September 30, 2024 and would like to discuss your legal rights, call Faruqi
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Flux Power To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Flux Power between November 11, 2022 and September 30, 2024 and would like to discuss your legal rights, call Faruqi
LOS ANGELES, CA / ACCESSWIRE / November 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder
LOS ANGELES, CA / ACCESSWIRE / November 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA Biologics" or "the Company") (NASDAQ:ADMA) for violations of the securities laws. According to the Complaint, the Company made false and
NEW YORK, NY / ACCESSWIRE / November 30, 2024 / Keeping employees safe is a primary obligation for employers, particularly for those operating in industries where fire hazards are a daily concern. Choosing the right flame-resistant clothing is a critical step toward minimizing potential fire-related injuries. Here are six essential factors to consider when choosing
https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline. So what: If you purchased Edwards securities during the Class Period
The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Celsius Holdings, Inc.(“Celsius”) (NASDAQ: CELH) on behalf of those who purchased or otherwise acquired Celsius common stock between February 29, 2024, and September 4, 2024, inclusive (the “Class Period”). The lead plaintiff deadline